Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 24, Issue 9, Pages 2938-2940Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfp278
Keywords
focal segmental; galactose; glomerulosclerosis; nephrotic syndrome; permeability factor
Categories
Ask authors/readers for more resources
Some cases of nephrotic syndrome in focal and segmental glomerulosclerosis (FSGS) are associated with a circulating factor, the FSGS permeability factor (FSPF). Galactose has a high affinity for FSPF, and experimental data suggest that it could reduce its activity. We describe the case of a 48-year-old male with a nephrotic syndrome found to be resistant to corticosteroids, immunosuppression and plasmaphaeresis. The patient was given oral galactose as a last resort treatment, which was followed by a remission of his nephrotic syndrome that correlated with a reduction of FSPF activity. This case is the first report of a long-standing remission of an FSPF-associated nephrotic syndrome on oral galactose therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available